283 filings
Page 11 of 15
6-K
480fjx
2 Feb 16
Kamada Reports 2015 Fourth Quarter and Full Year Financial Results
12:00am
6-K
3c1uff1iqprl7rbw hu
6 Jan 16
Kamada Reports Further Positive Interim Data from Phase 1/2 Study of its
12:00am
6-K
wo5jqjjk
23 Dec 15
Strategic agreement with Kedrion for clinical development and marketing
12:00am
6-K
cblzsvh56y96bhtbf
8 Dec 15
Kamada Completes Enrollment of U.S. Phase 2 Study of Inhaled Alpha-1
12:00am
6-K
sqg5c
2 Dec 15
Kamada Provides Update on Alpha-1 Antitrypsin Development in Newly Diagnosed
12:00am
6-K
omqlon 48bb23en
17 Nov 15
Current report (foreign)
12:00am
6-K
ie1n7e6cpynyh
10 Nov 15
Kamada Reports Third Quarter 2015 Financial Results
12:00am
6-K
6q9lej9 tixp0m
16 Oct 15
Kamada Announces Third Extension of Strategic Agreement with Baxalta
12:00am
6-K
hj067l
10 Aug 15
Current report (foreign)
12:00am
6-K
cbbd74ibt 032w6tfj
4 Aug 15
Kamada Appoints Michael Berelowitz, M.D. to its Board of Directors
12:00am
6-K
769t4f444k5xak91 s1
30 Jul 15
Kamada Reports Second Quarter 2015 Financial Results
12:00am
6-K
m1wa9c0b
8 Jul 15
Kamada Reports Revenue for First Half 2015 in Line with Plans
12:00am
6-K
ti62uou0
6 Jul 15
Kamada Announces Publication in Pediatric Diabetes
12:00am
6-K
c81dt 5di
1 Jul 15
Kamada Granted Key New Patent for Inhaled AAT and eFlow® Nebulizer System in Israel
12:00am
6-K
v12xb7vikoef8t7nl
30 Jun 15
Current report (foreign)
12:00am
6-K
rmb6rjkq2dtx 85dd0j
22 Jun 15
Current report (foreign)
12:00am
6-K
ddbsga5u bfbgfdq3da
3 Jun 15
Current report (foreign)
12:00am
6-K
fuge t77aj16n068nr
22 May 15
Current report (foreign)
12:00am
6-K
navxm 5z7kibbg8me7
20 May 15
Current report (foreign)
12:00am
6-K
gcihxyxn
20 May 15
Current report (foreign)
12:00am